A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis
- PMID: 14507756
- PMCID: PMC1920780
- DOI: 10.1136/bjo.87.10.1235
A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis
Abstract
Aim: To compare 2% econazole and 5% natamycin in the management of fungal keratitis.
Methods: A randomised clinical trial was performed using 2% econazole or 5% natamycin as the two treatment arms on patients presenting with culture positive fungal keratitis to the cornea service at Aravind Eye Care System, Madurai, India.
Results: 116 patients were recruited, and 112 continued in the study. There were no significant differences between the two arms at baseline or for success (defined as a healed or healing ulcer) at final visit (p = 0.79).
Conclusions: 2% Econazole appears to be as effective as 5% natamycin for the management of fungal keratitis.
Figures
References
-
- Rapoza PA, West SK, Katala SJ, et al. Prevalence and causes of vision loss in central Tanzania. Int Ophthalmol 1991;15:123–9. - PubMed
-
- Khan MU, Hague MR, Khan MR. Prevalence and causes of blindness in rural Bangladesh. Ind J Med Res 1985;82:257–62. - PubMed
-
- Gilbert CE, Wood M, Waddel K, et al. Causes of childhood blindness in East Africa: results in 491 pupils attending 17 schools for the blind in Malawi, Kenya and Uganda. Ophthalmic Epidemiol 1995;2:77–84. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources